InvestSMART

EMvision Medical Devices Limited (ASX:EMV)

ALERT: Price-sensitive ASX Announcement for EMV
Current share price for EMV : $1.695 0.025 (1.50%)+
Announcement
Release
25 May 2026 8:20AM
Price at Release
$1.670
Full Release
download
Summary
EMVision Medical Devices Limited announced it will receive a $1.17 million instalment from the Australian Government's Industry Growth Program (IGP), as part of a $5 million grant awarded in June 2025. This funding supports the commercialisation of EMVision's First Responder Brain Scanner, a lightweight device for pre-hospital use. The instalment reflects progress in the product's development and commercialisation. The grant is non-dilutive, with payments made quarterly based on forecast eligible expenditure and program milestones. To date, EMVision has received $1 million from the IGP, with $2.83 million remaining available.
Key Points
  • EMVision Medical Devices Limited announced the receipt of a $1.17 million grant instalment.
  • The grant is part of a $5 million non-dilutive Industry Growth Program (IGP) to support the First Responder Brain Scanner commercialisation.
  • Payments under the IGP are made quarterly and require demonstration of progress against program milestones.
  • To date, EMVision has received $1 million from the IGP, with $2.83 million remaining.
  • The First Responder Brain Scanner is designed for pre-hospital use in road and aeromedical settings.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.